Further investigations are required to reveal if modulating the expression, activity, or localization of proteins in the MAM interface has an impact on insulin action and if these strategies can be applied to the treatment of insulin resistance and T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.